Abnormality of p16/p38MAPK/p53/Wipl pathway in papillary thyroid cancer
Authors:
Open Access
- 1 May 2012
- journal article
- research article
- Vol. 1 (1) , 33-38-38
Abstract
Abnormality of p16/p38MAPK/p53/Wipl pathway in papillary thyroid cancerKeywords
This publication has 18 references indexed in Scilit:
- Increasing Incidence of Thyroid Cancer in Shanghai, China, 1983-2007Asia Pacific Journal of Public Health, 2012
- The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repairDNA Repair, 2010
- WIP1 phosphatase at the crossroads of cancer and agingTrends in Biochemical Sciences, 2010
- An Oncogene-Induced DNA Damage Model for Cancer DevelopmentScience, 2008
- Increased wild‐type p53‐induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinomaPathology International, 2007
- Development of a Substrate-Based Cyclic Phosphopeptide Inhibitor of Protein Phosphatase 2Cδ, Wip1Biochemistry, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23Nature Genetics, 2002
- Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityNature Genetics, 2002